These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3115348)

  • 21. Cost offset effect strategies for the provision of mental health care services.
    Kocakülâh MC; Valadares KJ
    J Health Care Finance; 2003; 30(1):31-40. PubMed ID: 12967242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotherapy assessment and treatment selection.
    Tillett R
    Br J Psychiatry; 1996 Jan; 168(1):10-5. PubMed ID: 8770421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotherapy in the NHS.
    Wilkinson G
    Lancet; 1984 Oct; 2(8409):988. PubMed ID: 6149385
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of cost-effectiveness for vascular surgery service provision in the United Kingdom.
    Mandavia R; Dharmarajah B; Qureshi MI; Davies AH
    J Vasc Surg; 2015 May; 61(5):1331-9. PubMed ID: 25925543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "value" of Project MATCH for service provision.
    Godfrey C
    Addiction; 1999 Jan; 94(1):54-5. PubMed ID: 10665093
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic grand rounds: financial disincentives for the provision of psychotherapy.
    West JC; Wilk JE; Rae DS; Narrow WE; Regier DA
    Psychiatr Serv; 2003 Dec; 54(12):1582-3, 1588. PubMed ID: 14645792
    [No Abstract]   [Full Text] [Related]  

  • 28. The cost-effectiveness of psychotherapy: a plan for research.
    Krupnick JL; Pincus HA
    Am J Psychiatry; 1992 Oct; 149(10):1295-305. PubMed ID: 1530066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and benefits of psychotherapy.
    Howard K; Marinovitch Z
    Acta Psychiatr Belg; 1996; 96(3-4):154-70. PubMed ID: 8766362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of psychotherapy for personality disorders: treatment recommendations and implementation.
    Soeteman DI; Kim JJ
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):73-81. PubMed ID: 23402448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strengthening the status of psychotherapy for personality disorders: an integrated perspective on effects and costs.
    Bartak A; Soeteman DI; Verheul R; Busschbach JJ
    Can J Psychiatry; 2007 Dec; 52(12):803-10. PubMed ID: 18186181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Walk the talk.
    Dent E
    Health Serv J; 2006 Aug; 116(6017):22-4. PubMed ID: 16958340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Economic Analysis of Psychotherapy for Borderline Personality Disorder Patients.
    Hall J; Caleo S; Stevenson J; Meares R
    J Ment Health Policy Econ; 2001 Mar; 4(1):3-8. PubMed ID: 11967460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of economic evaluations of interventions for high risk young people.
    Edmunds K; Ling R; Shakeshaft A; Doran C; Searles A
    BMC Health Serv Res; 2018 Aug; 18(1):660. PubMed ID: 30139384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cuts stifle talking therapy.
    Stephenson J
    Health Serv J; 2008 Feb; ():9. PubMed ID: 18396529
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimising waiting: a view from the English National Health Service.
    Harrison AJ; Appleby J
    Health Econ Policy Law; 2010 Oct; 5(4):397-409. PubMed ID: 20025834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation: what does a nurse manager need to know?
    Douglas HR; Normand C
    J Nurs Manag; 2005 Sep; 13(5):419-27. PubMed ID: 16108780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and emerging trends in the psychotherapy 'industry'.
    Eisen P
    Aust N Z J Psychiatry; 1983 Mar; 17(1):9-16. PubMed ID: 6409070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotherapy--a luxury the NHS cannot afford? More expensive not to treat.
    Holmes J
    BMJ; 1994 Oct; 309(6961):1070-1. PubMed ID: 7950744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.